nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP3A4—Calcitriol—osteoporosis	0.0506	0.158	CbGbCtD
Fingolimod—CYP3A4—Estropipate—osteoporosis	0.0506	0.158	CbGbCtD
Fingolimod—CYP2D6—Cholecalciferol—osteoporosis	0.041	0.128	CbGbCtD
Fingolimod—CYP3A4—Ergocalciferol—osteoporosis	0.0404	0.126	CbGbCtD
Fingolimod—CYP3A4—Raloxifene—osteoporosis	0.0337	0.106	CbGbCtD
Fingolimod—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0326	0.102	CbGbCtD
Fingolimod—CYP3A4—Cholecalciferol—osteoporosis	0.026	0.0815	CbGbCtD
Fingolimod—CYP3A4—Conjugated Estrogens—osteoporosis	0.0239	0.0748	CbGbCtD
Fingolimod—CYP3A4—Estradiol—osteoporosis	0.021	0.0657	CbGbCtD
Fingolimod—Infestation—Ethinyl Estradiol—osteoporosis	0.00122	0.00376	CcSEcCtD
Fingolimod—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.00122	0.00376	CcSEcCtD
Fingolimod—Mediastinal disorder—Estropipate—osteoporosis	0.00122	0.00375	CcSEcCtD
Fingolimod—Leukopenia—Etidronic acid—osteoporosis	0.00122	0.00375	CcSEcCtD
Fingolimod—Depression—Ethinyl Estradiol—osteoporosis	0.00122	0.00375	CcSEcCtD
Fingolimod—Cardiac disorder—Raloxifene—osteoporosis	0.00122	0.00374	CcSEcCtD
Fingolimod—Asthenia—Calcium Acetate—osteoporosis	0.00122	0.00373	CcSEcCtD
Fingolimod—Eye disorder—Ibandronate—osteoporosis	0.00121	0.00373	CcSEcCtD
Fingolimod—Cardiac disorder—Ibandronate—osteoporosis	0.00121	0.0037	CcSEcCtD
Fingolimod—Pneumonia—Risedronate—osteoporosis	0.0012	0.00368	CcSEcCtD
Fingolimod—Pruritus—Calcium Acetate—osteoporosis	0.0012	0.00368	CcSEcCtD
Fingolimod—Alopecia—Estropipate—osteoporosis	0.0012	0.00368	CcSEcCtD
Fingolimod—Infestation NOS—Risedronate—osteoporosis	0.00119	0.00366	CcSEcCtD
Fingolimod—Infestation—Risedronate—osteoporosis	0.00119	0.00366	CcSEcCtD
Fingolimod—Angiopathy—Raloxifene—osteoporosis	0.00119	0.00366	CcSEcCtD
Fingolimod—Depression—Risedronate—osteoporosis	0.00119	0.00365	CcSEcCtD
Fingolimod—Mental disorder—Estropipate—osteoporosis	0.00119	0.00365	CcSEcCtD
Fingolimod—Alopecia—Alendronate—osteoporosis	0.00118	0.00362	CcSEcCtD
Fingolimod—Angiopathy—Ibandronate—osteoporosis	0.00118	0.00362	CcSEcCtD
Fingolimod—Mediastinal disorder—Ibandronate—osteoporosis	0.00117	0.0036	CcSEcCtD
Fingolimod—Gastroenteritis—Estradiol—osteoporosis	0.00117	0.00359	CcSEcCtD
Fingolimod—Influenza—Zoledronate—osteoporosis	0.00116	0.00357	CcSEcCtD
Fingolimod—Diarrhoea—Calcium Acetate—osteoporosis	0.00116	0.00356	CcSEcCtD
Fingolimod—Eczema—Estradiol—osteoporosis	0.00115	0.00354	CcSEcCtD
Fingolimod—Alopecia—Ibandronate—osteoporosis	0.00115	0.00353	CcSEcCtD
Fingolimod—Sinusitis—Ethinyl Estradiol—osteoporosis	0.00115	0.00352	CcSEcCtD
Fingolimod—Back pain—Estropipate—osteoporosis	0.00114	0.0035	CcSEcCtD
Fingolimod—Pneumonia—Pamidronate—osteoporosis	0.00114	0.0035	CcSEcCtD
Fingolimod—Mental disorder—Ibandronate—osteoporosis	0.00114	0.0035	CcSEcCtD
Fingolimod—Infestation NOS—Pamidronate—osteoporosis	0.00113	0.00348	CcSEcCtD
Fingolimod—Infestation—Pamidronate—osteoporosis	0.00113	0.00348	CcSEcCtD
Fingolimod—Dizziness—Calcium Acetate—osteoporosis	0.00112	0.00344	CcSEcCtD
Fingolimod—Sinusitis—Risedronate—osteoporosis	0.00112	0.00344	CcSEcCtD
Fingolimod—Influenza—Conjugated Estrogens—osteoporosis	0.00112	0.00343	CcSEcCtD
Fingolimod—Infection—Etidronic acid—osteoporosis	0.00111	0.00339	CcSEcCtD
Fingolimod—Back pain—Ibandronate—osteoporosis	0.00109	0.00336	CcSEcCtD
Fingolimod—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.00108	0.00331	CcSEcCtD
Fingolimod—Bronchitis—Conjugated Estrogens—osteoporosis	0.00108	0.0033	CcSEcCtD
Fingolimod—Asthenia—Ergocalciferol—osteoporosis	0.00107	0.0033	CcSEcCtD
Fingolimod—Sinusitis—Pamidronate—osteoporosis	0.00106	0.00327	CcSEcCtD
Fingolimod—Cerebrovascular accident—Estradiol—osteoporosis	0.00106	0.00325	CcSEcCtD
Fingolimod—Connective tissue disorder—Risedronate—osteoporosis	0.00105	0.00323	CcSEcCtD
Fingolimod—Weight decreased—Zoledronate—osteoporosis	0.00105	0.00323	CcSEcCtD
Fingolimod—Palpitations—Estropipate—osteoporosis	0.00104	0.0032	CcSEcCtD
Fingolimod—Infestation NOS—Zoledronate—osteoporosis	0.00104	0.00318	CcSEcCtD
Fingolimod—Infestation—Zoledronate—osteoporosis	0.00104	0.00318	CcSEcCtD
Fingolimod—Depression—Zoledronate—osteoporosis	0.00103	0.00317	CcSEcCtD
Fingolimod—Cough—Estropipate—osteoporosis	0.00103	0.00316	CcSEcCtD
Fingolimod—Eye disorder—Ethinyl Estradiol—osteoporosis	0.00103	0.00315	CcSEcCtD
Fingolimod—Migraine—Estradiol—osteoporosis	0.00102	0.00313	CcSEcCtD
Fingolimod—Eye disorder—Risedronate—osteoporosis	0.001	0.00307	CcSEcCtD
Fingolimod—Connective tissue disorder—Pamidronate—osteoporosis	0.001	0.00307	CcSEcCtD
Fingolimod—Palpitations—Ibandronate—osteoporosis	0.001	0.00307	CcSEcCtD
Fingolimod—Paraesthesia—Etidronic acid—osteoporosis	0.001	0.00307	CcSEcCtD
Fingolimod—Infestation NOS—Conjugated Estrogens—osteoporosis	0.000998	0.00306	CcSEcCtD
Fingolimod—Infestation—Conjugated Estrogens—osteoporosis	0.000998	0.00306	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000998	0.00306	CcSEcCtD
Fingolimod—Cough—Raloxifene—osteoporosis	0.000998	0.00306	CcSEcCtD
Fingolimod—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000997	0.00306	CcSEcCtD
Fingolimod—Depression—Conjugated Estrogens—osteoporosis	0.000995	0.00305	CcSEcCtD
Fingolimod—Cardiac disorder—Risedronate—osteoporosis	0.000994	0.00305	CcSEcCtD
Fingolimod—Hypertension—Ibandronate—osteoporosis	0.000977	0.003	CcSEcCtD
Fingolimod—Angiopathy—Risedronate—osteoporosis	0.000972	0.00298	CcSEcCtD
Fingolimod—Alopecia—Ethinyl Estradiol—osteoporosis	0.000971	0.00298	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000966	0.00297	CcSEcCtD
Fingolimod—Mediastinal disorder—Risedronate—osteoporosis	0.000966	0.00296	CcSEcCtD
Fingolimod—Mental disorder—Ethinyl Estradiol—osteoporosis	0.000963	0.00295	CcSEcCtD
Fingolimod—Infection—Estropipate—osteoporosis	0.000957	0.00294	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000957	0.00294	CcSEcCtD
Fingolimod—Liver function test abnormal—Estradiol—osteoporosis	0.000957	0.00294	CcSEcCtD
Fingolimod—Hypertension—Calcitriol—osteoporosis	0.000956	0.00294	CcSEcCtD
Fingolimod—Eye disorder—Pamidronate—osteoporosis	0.000952	0.00292	CcSEcCtD
Fingolimod—Bradycardia—Zoledronate—osteoporosis	0.000947	0.00291	CcSEcCtD
Fingolimod—Cardiac disorder—Pamidronate—osteoporosis	0.000945	0.0029	CcSEcCtD
Fingolimod—Nervous system disorder—Estropipate—osteoporosis	0.000945	0.0029	CcSEcCtD
Fingolimod—Infection—Alendronate—osteoporosis	0.000942	0.00289	CcSEcCtD
Fingolimod—Mental disorder—Risedronate—osteoporosis	0.000939	0.00288	CcSEcCtD
Fingolimod—Sinusitis—Conjugated Estrogens—osteoporosis	0.000936	0.00287	CcSEcCtD
Fingolimod—Skin disorder—Estropipate—osteoporosis	0.000936	0.00287	CcSEcCtD
Fingolimod—Infection—Raloxifene—osteoporosis	0.000927	0.00284	CcSEcCtD
Fingolimod—Back pain—Ethinyl Estradiol—osteoporosis	0.000925	0.00284	CcSEcCtD
Fingolimod—Angiopathy—Pamidronate—osteoporosis	0.000924	0.00284	CcSEcCtD
Fingolimod—Mediastinal disorder—Pamidronate—osteoporosis	0.000918	0.00282	CcSEcCtD
Fingolimod—Infection—Ibandronate—osteoporosis	0.000918	0.00282	CcSEcCtD
Fingolimod—Nervous system disorder—Raloxifene—osteoporosis	0.000915	0.00281	CcSEcCtD
Fingolimod—Connective tissue disorder—Zoledronate—osteoporosis	0.000914	0.00281	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000914	0.00281	CcSEcCtD
Fingolimod—Skin disorder—Raloxifene—osteoporosis	0.000906	0.00278	CcSEcCtD
Fingolimod—Nervous system disorder—Ibandronate—osteoporosis	0.000906	0.00278	CcSEcCtD
Fingolimod—Back pain—Risedronate—osteoporosis	0.000902	0.00277	CcSEcCtD
Fingolimod—Alopecia—Pamidronate—osteoporosis	0.0009	0.00276	CcSEcCtD
Fingolimod—Skin disorder—Ibandronate—osteoporosis	0.000897	0.00275	CcSEcCtD
Fingolimod—Influenza—Estradiol—osteoporosis	0.000896	0.00275	CcSEcCtD
Fingolimod—Skin disorder—Calcitriol—osteoporosis	0.000878	0.0027	CcSEcCtD
Fingolimod—Eye disorder—Zoledronate—osteoporosis	0.000869	0.00267	CcSEcCtD
Fingolimod—Paraesthesia—Estropipate—osteoporosis	0.000865	0.00265	CcSEcCtD
Fingolimod—Cardiac disorder—Zoledronate—osteoporosis	0.000863	0.00265	CcSEcCtD
Fingolimod—Bronchitis—Estradiol—osteoporosis	0.000861	0.00264	CcSEcCtD
Fingolimod—Back pain—Pamidronate—osteoporosis	0.000858	0.00263	CcSEcCtD
Fingolimod—Angiopathy—Zoledronate—osteoporosis	0.000844	0.00259	CcSEcCtD
Fingolimod—Mediastinal disorder—Zoledronate—osteoporosis	0.000838	0.00257	CcSEcCtD
Fingolimod—Eye disorder—Conjugated Estrogens—osteoporosis	0.000837	0.00257	CcSEcCtD
Fingolimod—Cough—Ethinyl Estradiol—osteoporosis	0.000835	0.00256	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Estropipate—osteoporosis	0.000832	0.00255	CcSEcCtD
Fingolimod—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000831	0.00255	CcSEcCtD
Fingolimod—Fatigue—Estropipate—osteoporosis	0.00083	0.00255	CcSEcCtD
Fingolimod—Paraesthesia—Ibandronate—osteoporosis	0.000829	0.00255	CcSEcCtD
Fingolimod—Alopecia—Zoledronate—osteoporosis	0.000822	0.00252	CcSEcCtD
Fingolimod—Mental disorder—Zoledronate—osteoporosis	0.000815	0.0025	CcSEcCtD
Fingolimod—Cough—Risedronate—osteoporosis	0.000814	0.0025	CcSEcCtD
Fingolimod—Angiopathy—Conjugated Estrogens—osteoporosis	0.000813	0.00249	CcSEcCtD
Fingolimod—Weight decreased—Estradiol—osteoporosis	0.00081	0.00249	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000809	0.00248	CcSEcCtD
Fingolimod—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000807	0.00248	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000805	0.00247	CcSEcCtD
Fingolimod—Hypertension—Risedronate—osteoporosis	0.000805	0.00247	CcSEcCtD
Fingolimod—Pneumonia—Estradiol—osteoporosis	0.000803	0.00247	CcSEcCtD
Fingolimod—Infestation—Estradiol—osteoporosis	0.000799	0.00245	CcSEcCtD
Fingolimod—Infestation NOS—Estradiol—osteoporosis	0.000799	0.00245	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000797	0.00245	CcSEcCtD
Fingolimod—Depression—Estradiol—osteoporosis	0.000796	0.00244	CcSEcCtD
Fingolimod—Fatigue—Ibandronate—osteoporosis	0.000796	0.00244	CcSEcCtD
Fingolimod—Leukopenia—Pamidronate—osteoporosis	0.000794	0.00244	CcSEcCtD
Fingolimod—Alopecia—Conjugated Estrogens—osteoporosis	0.000792	0.00243	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000789	0.00242	CcSEcCtD
Fingolimod—Pruritus—Etidronic acid—osteoporosis	0.000788	0.00242	CcSEcCtD
Fingolimod—Mental disorder—Conjugated Estrogens—osteoporosis	0.000785	0.00241	CcSEcCtD
Fingolimod—Back pain—Zoledronate—osteoporosis	0.000783	0.0024	CcSEcCtD
Fingolimod—Infection—Ethinyl Estradiol—osteoporosis	0.000776	0.00238	CcSEcCtD
Fingolimod—Cough—Pamidronate—osteoporosis	0.000774	0.00237	CcSEcCtD
Fingolimod—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000766	0.00235	CcSEcCtD
Fingolimod—Hypertension—Pamidronate—osteoporosis	0.000765	0.00235	CcSEcCtD
Fingolimod—Vision blurred—Zoledronate—osteoporosis	0.000763	0.00234	CcSEcCtD
Fingolimod—Diarrhoea—Etidronic acid—osteoporosis	0.000762	0.00234	CcSEcCtD
Fingolimod—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000758	0.00233	CcSEcCtD
Fingolimod—Infection—Risedronate—osteoporosis	0.000756	0.00232	CcSEcCtD
Fingolimod—Back pain—Conjugated Estrogens—osteoporosis	0.000754	0.00231	CcSEcCtD
Fingolimod—Sinusitis—Estradiol—osteoporosis	0.000749	0.0023	CcSEcCtD
Fingolimod—Nervous system disorder—Risedronate—osteoporosis	0.000746	0.00229	CcSEcCtD
Fingolimod—Skin disorder—Risedronate—osteoporosis	0.000739	0.00227	CcSEcCtD
Fingolimod—Vision blurred—Conjugated Estrogens—osteoporosis	0.000735	0.00226	CcSEcCtD
Fingolimod—Leukopenia—Zoledronate—osteoporosis	0.000725	0.00222	CcSEcCtD
Fingolimod—Infection—Pamidronate—osteoporosis	0.000719	0.00221	CcSEcCtD
Fingolimod—Palpitations—Zoledronate—osteoporosis	0.000716	0.0022	CcSEcCtD
Fingolimod—Nervous system disorder—Pamidronate—osteoporosis	0.00071	0.00218	CcSEcCtD
Fingolimod—Cough—Zoledronate—osteoporosis	0.000707	0.00217	CcSEcCtD
Fingolimod—Connective tissue disorder—Estradiol—osteoporosis	0.000704	0.00216	CcSEcCtD
Fingolimod—Hypertension—Zoledronate—osteoporosis	0.000699	0.00215	CcSEcCtD
Fingolimod—Headache—Etidronic acid—osteoporosis	0.000697	0.00214	CcSEcCtD
Fingolimod—Asthenia—Estropipate—osteoporosis	0.000691	0.00212	CcSEcCtD
Fingolimod—Palpitations—Conjugated Estrogens—osteoporosis	0.000689	0.00211	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000685	0.0021	CcSEcCtD
Fingolimod—Paraesthesia—Risedronate—osteoporosis	0.000683	0.0021	CcSEcCtD
Fingolimod—Pruritus—Estropipate—osteoporosis	0.000681	0.00209	CcSEcCtD
Fingolimod—Asthenia—Alendronate—osteoporosis	0.000681	0.00209	CcSEcCtD
Fingolimod—Cough—Conjugated Estrogens—osteoporosis	0.00068	0.00209	CcSEcCtD
Fingolimod—Dyspnoea—Risedronate—osteoporosis	0.000679	0.00208	CcSEcCtD
Fingolimod—Hypotension—Pamidronate—osteoporosis	0.000676	0.00208	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000674	0.00207	CcSEcCtD
Fingolimod—Fatigue—Ethinyl Estradiol—osteoporosis	0.000673	0.00207	CcSEcCtD
Fingolimod—Pruritus—Alendronate—osteoporosis	0.000671	0.00206	CcSEcCtD
Fingolimod—Eye disorder—Estradiol—osteoporosis	0.00067	0.00206	CcSEcCtD
Fingolimod—Cardiac disorder—Estradiol—osteoporosis	0.000665	0.00204	CcSEcCtD
Fingolimod—Asthenia—Ibandronate—osteoporosis	0.000663	0.00203	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000659	0.00202	CcSEcCtD
Fingolimod—Diarrhoea—Estropipate—osteoporosis	0.000659	0.00202	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Risedronate—osteoporosis	0.000657	0.00202	CcSEcCtD
Fingolimod—Infection—Zoledronate—osteoporosis	0.000657	0.00202	CcSEcCtD
Fingolimod—Fatigue—Risedronate—osteoporosis	0.000656	0.00201	CcSEcCtD
Fingolimod—Pruritus—Ibandronate—osteoporosis	0.000653	0.00201	CcSEcCtD
Fingolimod—Angiopathy—Estradiol—osteoporosis	0.00065	0.002	CcSEcCtD
Fingolimod—Paraesthesia—Pamidronate—osteoporosis	0.00065	0.00199	CcSEcCtD
Fingolimod—Diarrhoea—Alendronate—osteoporosis	0.000649	0.00199	CcSEcCtD
Fingolimod—Asthenia—Calcitriol—osteoporosis	0.000649	0.00199	CcSEcCtD
Fingolimod—Nervous system disorder—Zoledronate—osteoporosis	0.000648	0.00199	CcSEcCtD
Fingolimod—Mediastinal disorder—Estradiol—osteoporosis	0.000646	0.00198	CcSEcCtD
Fingolimod—Dyspnoea—Pamidronate—osteoporosis	0.000645	0.00198	CcSEcCtD
Fingolimod—Skin disorder—Zoledronate—osteoporosis	0.000642	0.00197	CcSEcCtD
Fingolimod—Pruritus—Calcitriol—osteoporosis	0.00064	0.00196	CcSEcCtD
Fingolimod—Diarrhoea—Raloxifene—osteoporosis	0.000638	0.00196	CcSEcCtD
Fingolimod—Dizziness—Estropipate—osteoporosis	0.000637	0.00195	CcSEcCtD
Fingolimod—Alopecia—Estradiol—osteoporosis	0.000634	0.00194	CcSEcCtD
Fingolimod—Infection—Conjugated Estrogens—osteoporosis	0.000632	0.00194	CcSEcCtD
Fingolimod—Diarrhoea—Ibandronate—osteoporosis	0.000632	0.00194	CcSEcCtD
Fingolimod—Mental disorder—Estradiol—osteoporosis	0.000628	0.00193	CcSEcCtD
Fingolimod—Dizziness—Alendronate—osteoporosis	0.000627	0.00193	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000625	0.00192	CcSEcCtD
Fingolimod—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000624	0.00192	CcSEcCtD
Fingolimod—Fatigue—Pamidronate—osteoporosis	0.000624	0.00191	CcSEcCtD
Fingolimod—Diarrhoea—Calcitriol—osteoporosis	0.000619	0.0019	CcSEcCtD
Fingolimod—Skin disorder—Conjugated Estrogens—osteoporosis	0.000618	0.0019	CcSEcCtD
Fingolimod—Hypotension—Zoledronate—osteoporosis	0.000618	0.0019	CcSEcCtD
Fingolimod—Dizziness—Raloxifene—osteoporosis	0.000617	0.00189	CcSEcCtD
Fingolimod—Dizziness—Ibandronate—osteoporosis	0.000611	0.00187	CcSEcCtD
Fingolimod—Back pain—Estradiol—osteoporosis	0.000604	0.00185	CcSEcCtD
Fingolimod—Headache—Estropipate—osteoporosis	0.000603	0.00185	CcSEcCtD
Fingolimod—Hypotension—Conjugated Estrogens—osteoporosis	0.000595	0.00183	CcSEcCtD
Fingolimod—Headache—Alendronate—osteoporosis	0.000594	0.00182	CcSEcCtD
Fingolimod—Paraesthesia—Zoledronate—osteoporosis	0.000593	0.00182	CcSEcCtD
Fingolimod—Dyspnoea—Zoledronate—osteoporosis	0.000589	0.00181	CcSEcCtD
Fingolimod—Headache—Raloxifene—osteoporosis	0.000584	0.00179	CcSEcCtD
Fingolimod—Headache—Ibandronate—osteoporosis	0.000579	0.00178	CcSEcCtD
Fingolimod—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000571	0.00175	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000571	0.00175	CcSEcCtD
Fingolimod—Fatigue—Zoledronate—osteoporosis	0.00057	0.00175	CcSEcCtD
Fingolimod—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000567	0.00174	CcSEcCtD
Fingolimod—Headache—Calcitriol—osteoporosis	0.000566	0.00174	CcSEcCtD
Fingolimod—Asthenia—Ethinyl Estradiol—osteoporosis	0.00056	0.00172	CcSEcCtD
Fingolimod—Pruritus—Ethinyl Estradiol—osteoporosis	0.000552	0.0017	CcSEcCtD
Fingolimod—Palpitations—Estradiol—osteoporosis	0.000552	0.00169	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000549	0.00169	CcSEcCtD
Fingolimod—Fatigue—Conjugated Estrogens—osteoporosis	0.000549	0.00168	CcSEcCtD
Fingolimod—Asthenia—Risedronate—osteoporosis	0.000546	0.00168	CcSEcCtD
Fingolimod—Cough—Estradiol—osteoporosis	0.000545	0.00167	CcSEcCtD
Fingolimod—Hypertension—Estradiol—osteoporosis	0.000539	0.00165	CcSEcCtD
Fingolimod—Pruritus—Risedronate—osteoporosis	0.000539	0.00165	CcSEcCtD
Fingolimod—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000534	0.00164	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000528	0.00162	CcSEcCtD
Fingolimod—Diarrhoea—Risedronate—osteoporosis	0.000521	0.0016	CcSEcCtD
Fingolimod—Asthenia—Pamidronate—osteoporosis	0.000519	0.00159	CcSEcCtD
Fingolimod—Dizziness—Ethinyl Estradiol—osteoporosis	0.000516	0.00158	CcSEcCtD
Fingolimod—Pruritus—Pamidronate—osteoporosis	0.000512	0.00157	CcSEcCtD
Fingolimod—Infection—Estradiol—osteoporosis	0.000506	0.00155	CcSEcCtD
Fingolimod—Dizziness—Risedronate—osteoporosis	0.000503	0.00154	CcSEcCtD
Fingolimod—Nervous system disorder—Estradiol—osteoporosis	0.000499	0.00153	CcSEcCtD
Fingolimod—Diarrhoea—Pamidronate—osteoporosis	0.000495	0.00152	CcSEcCtD
Fingolimod—Skin disorder—Estradiol—osteoporosis	0.000495	0.00152	CcSEcCtD
Fingolimod—Headache—Ethinyl Estradiol—osteoporosis	0.000489	0.0015	CcSEcCtD
Fingolimod—Dizziness—Pamidronate—osteoporosis	0.000478	0.00147	CcSEcCtD
Fingolimod—Headache—Risedronate—osteoporosis	0.000477	0.00146	CcSEcCtD
Fingolimod—Asthenia—Zoledronate—osteoporosis	0.000474	0.00146	CcSEcCtD
Fingolimod—Pruritus—Zoledronate—osteoporosis	0.000468	0.00144	CcSEcCtD
Fingolimod—Paraesthesia—Estradiol—osteoporosis	0.000457	0.0014	CcSEcCtD
Fingolimod—Asthenia—Conjugated Estrogens—osteoporosis	0.000457	0.0014	CcSEcCtD
Fingolimod—Dyspnoea—Estradiol—osteoporosis	0.000454	0.00139	CcSEcCtD
Fingolimod—Headache—Pamidronate—osteoporosis	0.000453	0.00139	CcSEcCtD
Fingolimod—Diarrhoea—Zoledronate—osteoporosis	0.000452	0.00139	CcSEcCtD
Fingolimod—Pruritus—Conjugated Estrogens—osteoporosis	0.00045	0.00138	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Estradiol—osteoporosis	0.00044	0.00135	CcSEcCtD
Fingolimod—Fatigue—Estradiol—osteoporosis	0.000439	0.00135	CcSEcCtD
Fingolimod—Dizziness—Zoledronate—osteoporosis	0.000437	0.00134	CcSEcCtD
Fingolimod—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000435	0.00134	CcSEcCtD
Fingolimod—Dizziness—Conjugated Estrogens—osteoporosis	0.000421	0.00129	CcSEcCtD
Fingolimod—Headache—Zoledronate—osteoporosis	0.000414	0.00127	CcSEcCtD
Fingolimod—Headache—Conjugated Estrogens—osteoporosis	0.000399	0.00122	CcSEcCtD
Fingolimod—Asthenia—Estradiol—osteoporosis	0.000365	0.00112	CcSEcCtD
Fingolimod—Pruritus—Estradiol—osteoporosis	0.00036	0.00111	CcSEcCtD
Fingolimod—Diarrhoea—Estradiol—osteoporosis	0.000348	0.00107	CcSEcCtD
Fingolimod—Dizziness—Estradiol—osteoporosis	0.000337	0.00103	CcSEcCtD
Fingolimod—Headache—Estradiol—osteoporosis	0.000319	0.000979	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—ENO1—osteoporosis	0.000228	0.000644	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CNR2—osteoporosis	0.000227	0.000641	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—ADCY5—osteoporosis	0.000225	0.000636	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADCY5—osteoporosis	0.000225	0.000636	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADCY5—osteoporosis	0.000225	0.000636	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PSMA2—osteoporosis	0.000225	0.000634	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PSMA5—osteoporosis	0.000225	0.000634	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NFATC1—osteoporosis	0.000223	0.00063	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000223	0.000629	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DKK1—osteoporosis	0.000222	0.000625	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTHLH—osteoporosis	0.000221	0.000623	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BMP2—osteoporosis	0.000221	0.000623	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—FGB—osteoporosis	0.000216	0.00061	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—WNT1—osteoporosis	0.000214	0.000602	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTHLH—osteoporosis	0.000213	0.0006	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTHLH—osteoporosis	0.000213	0.0006	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BMP2—osteoporosis	0.000213	0.0006	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BMP2—osteoporosis	0.000213	0.0006	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—LEP—osteoporosis	0.000213	0.0006	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—P4HB—osteoporosis	0.000212	0.000598	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000211	0.000596	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CYP19A1—osteoporosis	0.000211	0.000596	CbGpPWpGaD
Fingolimod—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00021	0.000592	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PSMA2—osteoporosis	0.000209	0.000589	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PSMA5—osteoporosis	0.000209	0.000589	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FGB—osteoporosis	0.000208	0.000587	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FGB—osteoporosis	0.000208	0.000587	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FGA—osteoporosis	0.000208	0.000586	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTH—osteoporosis	0.000206	0.000582	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—ADCY5—osteoporosis	0.000205	0.000578	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000203	0.000573	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RAP1A—osteoporosis	0.000203	0.000572	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CNR2—osteoporosis	0.000201	0.000567	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PSMA2—osteoporosis	0.000201	0.000567	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PSMA5—osteoporosis	0.000201	0.000567	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PSMA2—osteoporosis	0.000201	0.000567	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PSMA5—osteoporosis	0.000201	0.000567	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000201	0.000567	CbGpPWpGaD
Fingolimod—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.0002	0.000565	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.0002	0.000565	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFATC1—osteoporosis	0.000198	0.000558	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DKK1—osteoporosis	0.000196	0.000554	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ENO1—osteoporosis	0.000196	0.000553	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CALCA—osteoporosis	0.000195	0.000549	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTHLH—osteoporosis	0.000193	0.000545	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BMP2—osteoporosis	0.000193	0.000545	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PSMA2—osteoporosis	0.000193	0.000545	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PSMA5—osteoporosis	0.000193	0.000545	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—POMC—osteoporosis	0.00019	0.000535	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—WNT1—osteoporosis	0.000189	0.000533	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FGB—osteoporosis	0.000189	0.000533	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CALCA—osteoporosis	0.000187	0.000528	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CALCA—osteoporosis	0.000187	0.000528	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGA—osteoporosis	0.000184	0.000519	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—POMC—osteoporosis	0.000183	0.000515	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—POMC—osteoporosis	0.000183	0.000515	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—POMC—osteoporosis	0.000183	0.000515	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PSMA5—osteoporosis	0.000182	0.000515	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PSMA2—osteoporosis	0.000182	0.000515	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CYP19A1—osteoporosis	0.000182	0.000514	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KL—osteoporosis	0.000177	0.000498	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—IGF1—osteoporosis	0.000176	0.000496	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ADCY5—osteoporosis	0.000173	0.000487	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—POMC—osteoporosis	0.000172	0.000486	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GPX1—osteoporosis	0.000172	0.000485	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTHLH—osteoporosis	0.000171	0.000482	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BMP2—osteoporosis	0.000171	0.000482	CbGpPWpGaD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.00017	0.00048	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KL—osteoporosis	0.00017	0.00048	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KL—osteoporosis	0.00017	0.00048	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CALCA—osteoporosis	0.00017	0.00048	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6R—osteoporosis	0.000168	0.000474	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGB—osteoporosis	0.000167	0.000472	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—POMC—osteoporosis	0.000166	0.000468	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—POMC—osteoporosis	0.000166	0.000468	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—POMC—osteoporosis	0.000166	0.000468	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000162	0.000457	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6R—osteoporosis	0.000162	0.000456	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6R—osteoporosis	0.000162	0.000456	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PSMA2—osteoporosis	0.000161	0.000456	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PSMA5—osteoporosis	0.000161	0.000456	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00016	0.000451	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MTHFR—osteoporosis	0.000159	0.000448	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP19A1—osteoporosis	0.000157	0.000442	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KL—osteoporosis	0.000154	0.000436	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—POMC—osteoporosis	0.000151	0.000425	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CALCA—osteoporosis	0.00015	0.000425	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	0.00015	0.000424	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ADCY5—osteoporosis	0.000149	0.00042	CbGpPWpGaD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000149	0.00042	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GPX1—osteoporosis	0.000148	0.000419	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000148	0.000418	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6R—osteoporosis	0.000147	0.000414	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ADCY5—osteoporosis	0.000138	0.00039	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MTHFR—osteoporosis	0.000137	0.000387	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KL—osteoporosis	0.000137	0.000385	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SPP1—osteoporosis	0.000134	0.000378	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADCY5—osteoporosis	0.000133	0.000376	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADCY5—osteoporosis	0.000133	0.000376	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000133	0.000375	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000131	0.000371	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000131	0.00037	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SPP1—osteoporosis	0.000129	0.000364	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SPP1—osteoporosis	0.000129	0.000364	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ADCY5—osteoporosis	0.000128	0.000361	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GPX1—osteoporosis	0.000128	0.00036	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—POMC—osteoporosis	0.000127	0.000358	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IRS2—osteoporosis	0.000121	0.000342	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADCY5—osteoporosis	0.000121	0.000341	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000121	0.000341	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—LEP—osteoporosis	0.000118	0.000334	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MTHFR—osteoporosis	0.000118	0.000332	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SPP1—osteoporosis	0.000117	0.00033	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IRS2—osteoporosis	0.000117	0.000329	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IRS2—osteoporosis	0.000117	0.000329	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—LEP—osteoporosis	0.000114	0.000322	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—LEP—osteoporosis	0.000114	0.000322	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ESR1—osteoporosis	0.000113	0.000319	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—POMC—osteoporosis	0.00011	0.000309	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ESR1—osteoporosis	0.000109	0.000307	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ESR1—osteoporosis	0.000109	0.000307	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADCY5—osteoporosis	0.000107	0.000302	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	0.000107	0.000301	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IRS2—osteoporosis	0.000106	0.000299	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IRS1—osteoporosis	0.000106	0.000298	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000105	0.000297	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SPP1—osteoporosis	0.000104	0.000292	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—LEP—osteoporosis	0.000104	0.000292	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—POMC—osteoporosis	0.000102	0.000287	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IRS1—osteoporosis	0.000102	0.000287	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IRS1—osteoporosis	0.000102	0.000287	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6R—osteoporosis	9.93e-05	0.00028	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ESR1—osteoporosis	9.89e-05	0.000279	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—POMC—osteoporosis	9.8e-05	0.000276	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—POMC—osteoporosis	9.8e-05	0.000276	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF1—osteoporosis	9.79e-05	0.000276	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.74e-05	0.000275	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6R—osteoporosis	9.56e-05	0.00027	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6R—osteoporosis	9.56e-05	0.00027	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1—osteoporosis	9.42e-05	0.000266	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1—osteoporosis	9.42e-05	0.000266	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—POMC—osteoporosis	9.42e-05	0.000266	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IRS2—osteoporosis	9.37e-05	0.000264	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IRS1—osteoporosis	9.24e-05	0.000261	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—LEP—osteoporosis	9.17e-05	0.000259	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—POMC—osteoporosis	9.04e-05	0.000255	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—POMC—osteoporosis	8.9e-05	0.000251	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ESR1—osteoporosis	8.75e-05	0.000247	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6R—osteoporosis	8.68e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1—osteoporosis	8.56e-05	0.000241	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FDPS—osteoporosis	8.53e-05	0.000241	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PKM—osteoporosis	8.53e-05	0.000241	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IRS1—osteoporosis	8.18e-05	0.000231	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPD2—osteoporosis	8.08e-05	0.000228	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PGLS—osteoporosis	8.08e-05	0.000228	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.9e-05	0.000223	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—POMC—osteoporosis	7.87e-05	0.000222	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6R—osteoporosis	7.68e-05	0.000217	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1—osteoporosis	7.57e-05	0.000214	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—osteoporosis	7.49e-05	0.000211	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ATIC—osteoporosis	7.39e-05	0.000209	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PNP—osteoporosis	7.39e-05	0.000209	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—osteoporosis	7.21e-05	0.000203	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—osteoporosis	7.21e-05	0.000203	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.98e-05	0.000197	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.88e-05	0.000194	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—osteoporosis	6.54e-05	0.000185	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—POMC—osteoporosis	6.41e-05	0.000181	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—OXCT1—osteoporosis	6.29e-05	0.000177	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA2—osteoporosis	6.29e-05	0.000177	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MGLL—osteoporosis	6.13e-05	0.000173	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PKM—osteoporosis	6.05e-05	0.000171	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FDPS—osteoporosis	6.05e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—osteoporosis	5.88e-05	0.000166	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—osteoporosis	5.87e-05	0.000166	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPD2—osteoporosis	5.74e-05	0.000162	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PGLS—osteoporosis	5.74e-05	0.000162	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—osteoporosis	5.66e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—osteoporosis	5.66e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—osteoporosis	5.65e-05	0.000159	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—osteoporosis	5.65e-05	0.000159	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PNP—osteoporosis	5.25e-05	0.000148	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ATIC—osteoporosis	5.25e-05	0.000148	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—IDH2—osteoporosis	5.21e-05	0.000147	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—osteoporosis	5.14e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—osteoporosis	5.13e-05	0.000145	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP27A1—osteoporosis	4.9e-05	0.000138	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ACP5—osteoporosis	4.76e-05	0.000134	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—osteoporosis	4.55e-05	0.000128	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—osteoporosis	4.54e-05	0.000128	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA2—osteoporosis	4.46e-05	0.000126	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—OXCT1—osteoporosis	4.46e-05	0.000126	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TPI1—osteoporosis	4.43e-05	0.000125	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—osteoporosis	4.42e-05	0.000125	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MGLL—osteoporosis	4.35e-05	0.000123	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—osteoporosis	4.26e-05	0.00012	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—osteoporosis	4.26e-05	0.00012	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—POMC—osteoporosis	4.19e-05	0.000118	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—P4HB—osteoporosis	4.16e-05	0.000117	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GAPDH—osteoporosis	4.09e-05	0.000115	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RAP1A—osteoporosis	3.98e-05	0.000112	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FDPS—osteoporosis	3.96e-05	0.000112	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PKM—osteoporosis	3.96e-05	0.000112	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—osteoporosis	3.87e-05	0.000109	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPD2—osteoporosis	3.75e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PGLS—osteoporosis	3.75e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—IDH2—osteoporosis	3.7e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.47e-05	9.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PNP—osteoporosis	3.43e-05	9.67e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ATIC—osteoporosis	3.43e-05	9.67e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—osteoporosis	3.42e-05	9.65e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ACP5—osteoporosis	3.38e-05	9.54e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO1—osteoporosis	3.22e-05	9.08e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSMA2—osteoporosis	3.17e-05	8.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSMA5—osteoporosis	3.17e-05	8.94e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TPI1—osteoporosis	3.14e-05	8.86e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—P4HB—osteoporosis	2.95e-05	8.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA2—osteoporosis	2.92e-05	8.23e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—OXCT1—osteoporosis	2.92e-05	8.23e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GAPDH—osteoporosis	2.9e-05	8.18e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MGLL—osteoporosis	2.84e-05	8.02e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RAP1A—osteoporosis	2.82e-05	7.97e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP19A1—osteoporosis	2.57e-05	7.26e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—IDH2—osteoporosis	2.42e-05	6.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO1—osteoporosis	2.28e-05	6.44e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.27e-05	6.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSMA2—osteoporosis	2.25e-05	6.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSMA5—osteoporosis	2.25e-05	6.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACP5—osteoporosis	2.21e-05	6.23e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADCY5—osteoporosis	2.1e-05	5.93e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX1—osteoporosis	2.09e-05	5.91e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TPI1—osteoporosis	2.05e-05	5.8e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—osteoporosis	1.93e-05	5.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—P4HB—osteoporosis	1.93e-05	5.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GAPDH—osteoporosis	1.9e-05	5.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RAP1A—osteoporosis	1.85e-05	5.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.83e-05	5.15e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—POMC—osteoporosis	1.55e-05	4.36e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO1—osteoporosis	1.49e-05	4.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADCY5—osteoporosis	1.49e-05	4.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX1—osteoporosis	1.49e-05	4.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSMA2—osteoporosis	1.47e-05	4.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSMA5—osteoporosis	1.47e-05	4.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—osteoporosis	1.37e-05	3.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.19e-05	3.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—POMC—osteoporosis	1.1e-05	3.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADCY5—osteoporosis	9.75e-06	2.75e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX1—osteoporosis	9.72e-06	2.74e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—osteoporosis	8.97e-06	2.53e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—POMC—osteoporosis	7.17e-06	2.02e-05	CbGpPWpGaD
